A PMHNP in a full practice authority state has been providing telehealth services to a patient with generalized anxiety disorder and panic disorder. After 8 weeks of SSRI therapy with partial response, the patient requests a benzodiazepine prescription. The PMHNP practices exclusively via telehealth and has never met the patient in person. The PMHNP reviews the applicable federal and state telehealth prescribing regulations. Which of the following best represents the regulatory framework for prescribing controlled substances via telehealth?